Tafasitamab

How A Doctor Cured His Own Terminal Disease | Dr. David Fajgenbaum

Andrew Huberman

A drug originally developed in Japan for Castleman's disease, but later repurposed and approved in the US for rheumatoid arthritis and other autoimmune diseases.